Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.9698
  • Today's Change0.008 / 0.81%
  • Shares traded170.88k
  • 1 Year change-0.02%
  • Beta0.2640
Data delayed at least 20 minutes, as of Dec 08 2022 13:47 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

BioPharma Credit PLC is a United Kingdom-based, closed-ended investment trust. The principal activity of the Company is to invest in interest-bearing-debt assets with a contractual right to future cash flows derived from royalties or sales of approved life sciences products. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve its investment objectives through direct or indirect exposure to debt assets. Its diversified portfolio is primarily secured by cash flows derived from sales of approved life sciences products. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its portfolio of investments includes senior secured corporate loans, senior secured royalty loans, unsecured convertible bonds, and equity. The Company's investment manager is Pharmakon Advisors L.P.

  • Revenue in USD (TTM)127.78m
  • Net income in USD108.88m
  • Incorporated2016
  • Employees0.00
  • Location
    BioPharma Credit PLCBeaufort HSE, 51 New North RoadEXETER EX4 4EPUnited KingdomGBR
  • Phone+44 139 247 7503
  • Websitehttp://bpcruk.com/#
More ▼

Profile

Management group(s)Pharmakon Advisors L.P.
AIC sectorDebt - Direct Lending
ISINGB00BDGKMY29
Launch date27 Mar 2017
Share typeOrdinary Share
StructureInvestment Trust
Base currencyUSD

Objective

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.

Managed by

Pedro Gonzalez de Cosio, Pablo Legorreta, Martin Friedman

Management & contract fees

Annual management fee is 1% of NAV. The performance fee is calculated as 10% of returns, subject to High Watermark and a 6% preferred return hurdle with 50% catch up.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AVI Global Trust PLC-116.79m-135.46m1.13bn0.00--0.9591-----0.2227-0.2227-0.19021.97-0.0808-------9.375.47-9.665.63--84.88--81.16---130.340.112528.25-130.83---137.06----6.58
Gresham House Energy Storage Fund PLC234.98m226.88m1.13bn0.004.141.18--4.810.41340.41340.43391.450.3288--832.43--31.75--31.83--97.41--96.55------0.00--267.54--330.16------
Murray Income Trust plc-40.24m-50.15m1.17bn0.00--0.9562-----0.3537-0.3537-0.28238.65-0.0282-------3.513.92-3.533.98--88.07--83.70----0.104189.61-119.72---125.49----1.91
Hipgnosis Songs Fund Ltd200.42m-19.45m1.17bn41.00--0.743213.745.86-0.014-0.0140.13971.070.0929--1.594,006,509.00-0.901---0.9245--80.72---9.70----0.66390.2729--24.59---149.94------
Law Debenture Corporation plc-16.27m-78.67m1.20bn222.00--1.24-----0.5195-0.5195-0.10846.22-0.0133-----60,054.05-6.447.37-6.667.56--94.02--63.61---9.700.178143.41384.184.674,943.483.6753.0511.67
TR Property Investment Trust plc-506.57m-543.89m1.22bn0.00--0.9879-----1.40-1.40-1.313.19-0.300-------32.219.39-33.839.77--88.06--84.20---141.580.054933.2726.3826.7920.1727.69--6.67
Biopharma Credit PLC127.78m108.88m1.28bn0.0012.140.9551--10.000.07930.07930.0931.010.0925--3.56--7.88--7.90--87.57--85.21------0.00---5.59---4.69------
Edinburgh Investment Trust PLC-103.88m-122.49m1.29bn0.00--1.06-----0.5909-0.5909-0.49725.93-0.0706-------8.330.5585-8.780.5747--40.11--31.61----0.1069660.95-46.49-5.81-49.41-5.93----
Aberforth Smaller Companies Trust plc-292.91m-310.72m1.34bn0.00--0.9395-----2.93-2.93-2.7413.73-0.1692-------17.957.42-17.977.45--91.60--88.01---219.680.046432.45283.9638.86267.6742.59--5.18
Herald Investment Trust plc-427.84m-448.62m1.35bn0.00--0.8708-----5.78-5.78-5.4520.37-0.2351-------24.6518.69-24.6818.76--94.88--94.38----0.000.00-28.8314.28-30.8314.29----
Octopus Titan VCT PLC-143.45m-183.34m1.35bn0.00--0.9471-----0.1168-0.1168-0.09660.9133-0.0935-------11.95---12.24--------------0.00--170.75--187.50------
Ruffer Investment Company Ltd46.85m36.13m1.36bn0.0025.811.05--29.100.12050.12050.15342.950.0494--2.15--3.815.433.875.5080.6885.1377.1182.15----0.0017.38-47.792.68-56.320.577--1.24
Fidelity China Special Situations PLC-585.89m-617.71m1.40bn0.00--0.9572-----0.985-0.985-0.9352.44-0.291-------30.684.14-32.674.37--75.68--71.92---2,060.940.068832.90-171.04---176.09----17.08
SDCL Energy Efficiency Income Trust PLC108.30m97.31m1.42bn0.0010.930.9708--13.140.09630.09630.11151.080.1003--232.36--9.01--9.03--91.57--89.86------0.00--134.61--146.13------
Vietnam Enterprise Investments Limited-550.29m-436.96m1.45bn0.00--0.7185-----1.70-1.70-2.128.00-0.2397-------19.0420.46-19.1120.92--98.27--105.97----0.000.00105.8433.59153.8035.76----
Syncona Ltd280.56m259.10m1.47bn0.005.730.8791--5.220.31310.31310.34012.040.1804--40.90--16.667.1716.787.24--92.4192.3579.67----0.008.40-76.20-26.29-83.37-35.19----
Data as of Dec 08 2022. Currency figures normalised to BioPharma Credit PLC's reporting currency: US Dollar USD

Institutional shareholders

40.24%Per cent of shares held by top holders
HolderShares% Held
Newton Investment Management Ltd.as of 31 Dec 2021136.38m10.17%
Adage Capital Management LPas of 31 Dec 2021130.85m9.76%
Sarasin & Partners LLPas of 13 Oct 202269.50m5.18%
M&G Investment Management Ltd.as of 31 Dec 202167.22m5.01%
Handelsbanken Wealth & Asset Management Ltd.as of 02 Sep 202228.81m2.15%
Credit Suisse Asset Management (Schweiz) AGas of 02 Sep 202225.57m1.91%
Pyrford International Ltd.as of 02 Sep 202225.29m1.89%
Columbia Management Investment Advisers LLCas of 02 Sep 202220.64m1.54%
Aberdeen Asset Managers Ltd.as of 02 Sep 202218.53m1.38%
JPMorgan Chase Bank, NA (Investment Management)as of 02 Sep 202216.66m1.24%
More ▼
Data from 30 Jun 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.